cagrilintide-semaglutide Cagrilintide–semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study New semaglutide and cagrilintide/semaglutide results

Our team can also advise on whether a blood test makes sense before your appointment

Preventing Unsafe Injection Practices: aseptic preparation, new sterile needles and syringes, multi-dose vial handling, and discard guidance

Each pen of BPC-157 + TB-500 (Blend) contains 200 units

Wound healing and skin repair GHK-Cu wound healing properties make it valuable for post-procedure recovery and general skin repair

This synthetic peptide acts as a triple incretin receptor agonist, hitting the GLP-1, GIP and glucagon receptors in parallel a mechanism that places it among the most intricate agonists available for preclinical metabolic signalling work

They have been extensively studied in large randomised controlled trials, with success rates of 60-70% across various causes of ED